Orhan Cam / Shutterstock.com
The US House of Representatives Judiciary Committee will hold a hearing on the Innovation Act tomorrow (April 14), during which testaments will be given by representatives from Eli Lilly and the Biotechnology Industry Organization (BIO).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
US House of Representatives Judiciary Committee, Innovation Act, Bob Goodlatte, non-practicing entities, patent reform
